Nuclear Imaging Devices Market Outlook, Size, Share, Key Companies, Market Trends, Growth factors by

Nuclear Imaging Devices Market Outlook, Size, Share, Key Companies, Market Trends, Growth factors by

Market Highlights

The global Nuclear Imaging Devices Market Share is expected to grow significantly over the forecast period. It is anticipated that the market is projected to register a CAGR of 5.1% over the forecast period 2023-2032.

The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.

Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.

However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.

Key Players

the global nuclear imaging devices market players are

  • Philips Healthcare,
  • Digirad Corporation,
  • Neusoft Medical Systems Co., Ltd.,
  • Progenics Pharmaceuticals Inc.,
  • Cannon Inc.,
  • Surgiceye GmbH,
  • CMR Naviscan,
  • Mediso Medical Imaging Systems Ltd.,
  • Agfa-Gevaert Group,
  • General Electric Company,
  • DDD-Diagnostic A/S,
  • Spectrum Dynamics Medical,
  • FMI Medical Systems, Inc.,
  • Segamicorp, and others.


The global nuclear imaging devices market is segmented based on technology, application, end user, and region.

  • The global nuclear imaging devices market outlook, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.
  • Based on application, the market is segmented into oncology, cardiology, neurology, and others.
  • Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.
  • The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Regional Analysis

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The nuclear imaging devices market insights in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Scroll to Top